1. Home
  2. NTWK vs CASI Comparison

NTWK vs CASI Comparison

Compare NTWK & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTWK
  • CASI
  • Stock Information
  • Founded
  • NTWK 1997
  • CASI 1991
  • Country
  • NTWK United States
  • CASI China
  • Employees
  • NTWK N/A
  • CASI N/A
  • Industry
  • NTWK Computer Software: Prepackaged Software
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTWK Technology
  • CASI Health Care
  • Exchange
  • NTWK Nasdaq
  • CASI Nasdaq
  • Market Cap
  • NTWK 28.0M
  • CASI 29.7M
  • IPO Year
  • NTWK 1998
  • CASI 1996
  • Fundamental
  • Price
  • NTWK $2.95
  • CASI $1.86
  • Analyst Decision
  • NTWK
  • CASI Strong Buy
  • Analyst Count
  • NTWK 0
  • CASI 1
  • Target Price
  • NTWK N/A
  • CASI $4.00
  • AVG Volume (30 Days)
  • NTWK 22.7K
  • CASI 7.6K
  • Earning Date
  • NTWK 05-14-2025
  • CASI 05-16-2025
  • Dividend Yield
  • NTWK N/A
  • CASI N/A
  • EPS Growth
  • NTWK N/A
  • CASI N/A
  • EPS
  • NTWK 0.02
  • CASI N/A
  • Revenue
  • NTWK $64,127,568.00
  • CASI $31,368,000.00
  • Revenue This Year
  • NTWK N/A
  • CASI N/A
  • Revenue Next Year
  • NTWK N/A
  • CASI N/A
  • P/E Ratio
  • NTWK $145.04
  • CASI N/A
  • Revenue Growth
  • NTWK 9.18
  • CASI 8.39
  • 52 Week Low
  • NTWK $2.14
  • CASI $1.64
  • 52 Week High
  • NTWK $3.34
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • NTWK 66.32
  • CASI 45.93
  • Support Level
  • NTWK $2.81
  • CASI $1.82
  • Resistance Level
  • NTWK $2.93
  • CASI $2.00
  • Average True Range (ATR)
  • NTWK 0.09
  • CASI 0.08
  • MACD
  • NTWK 0.00
  • CASI 0.01
  • Stochastic Oscillator
  • NTWK 100.00
  • CASI 39.96

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: